APELIN: A PROMISING THERAPEUTIC TARGET? (PART 1)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HASSANIPOUR MAHSA; SHAFAROODI HAMED

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF PHARMACEUTICAL & HEALTH SCIENCES Year:2014 | Volume:3 | Issue:1 Page(s): 69-74

Download Full-Text

Persian Verion

View:

645

Download:

157

Cites:

Information Journal Paper

Title

APELIN: A PROMISING THERAPEUTIC TARGET? (PART 1)

Author(s)

HASSANIPOUR MAHSA | SHAFAROODI HAMED | Issue Writer Certificate

Keywords

APELINQ1

APJQ1

G-PROTEIN COUPLED RECEPTORQ1

HEART FAILUREQ1

NITRIC OXIDEQ1

HYPERTENSIONQ1

ATHEROSCLEROSISQ1

Abstract

APELIN is a recently discovered bioactive peptide, known to be an endogenous high-affinity ligand for the previously orphan G protein-coupled receptor APJ. APELIN/APJ as a novel signaling pathway has been shown to play many crucial roles in cardiovascular function, blood pressure regulation, fluid homeostasis, feeding behavior, obesity, type 2 diabetes mellitus, adipoinsular axis regulation, cell proliferation, angiogenesis, neuroprotection and thermoregulation. This ubiquitous peptide opens a new field of research in biology and medicine. In this regard, the aim of this short review is to compile the evidence for the APELIN involvement in modulation of cardiovascular system and introduction of this new peptidic pathway as a useful drug target in the treatment of cardiovascular diseases in future.

Cites

No record.

References

Cite

APA: Copy

HASSANIPOUR, MAHSA, & SHAFAROODI, HAMED. (2014). APELIN: A PROMISING THERAPEUTIC TARGET? (PART 1). JOURNAL OF PHARMACEUTICAL & HEALTH SCIENCES, 3(1), 69-74. SID. https://sid.ir/paper/188740/en

Vancouver: Copy

HASSANIPOUR MAHSA, SHAFAROODI HAMED. APELIN: A PROMISING THERAPEUTIC TARGET? (PART 1). JOURNAL OF PHARMACEUTICAL & HEALTH SCIENCES[Internet]. 2014;3(1):69-74. Available from: https://sid.ir/paper/188740/en

IEEE: Copy

MAHSA HASSANIPOUR, and HAMED SHAFAROODI, “APELIN: A PROMISING THERAPEUTIC TARGET? (PART 1),” JOURNAL OF PHARMACEUTICAL & HEALTH SCIENCES, vol. 3, no. 1, pp. 69–74, 2014, [Online]. Available: https://sid.ir/paper/188740/en

Related Journal Papers